Abraxis BioScience Australia Pty Ltd

Regulatory activities for this sponsor.

4 result(s) found, displaying 1 to 4

ABRAXANE nanoparticle albumin-bound paclitaxel 250 mg powder for injection (suspension) vial (297973)

7 December 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ABRAXANE nanoparticle albumin-bound paclitaxel 250 mg powder for injection (suspension) vial.
AusPAR: Nanoparticle albumin-bound (nab) paclitaxel

17 June 2014

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Nanoparticle albumin-bound (nab) paclitaxel
AusPAR: Nanoparticle albumin-bound (nab) paclitaxel

9 January 2014

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Nanoparticle albumin-bound (nab) paclitaxel
ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial (133500)

17 October 2008

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial.